If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 203.50
Bid: 201.00
Ask: 203.00
Change: 1.00 (0.49%)
Spread: 2.00 (0.995%)
Open: 200.00
High: 207.50
Low: 200.00
Prev. Close: 202.50
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Acquisition

20 Dec 2011 08:20

RNS Number : 3070U
Advanced Medical Solutions Grp PLC
20 December 2011
 

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. All DEFINed terms in this announcement have the meaning GIVEN TO THEM IN THE ANNOUNCEMENT MADE BY THE COMPANY ON 2 DECEMBER 2011 (RNS Number: 2417T).

 

20 December 2011

Advanced Medical Solutions Group plc

("AMS" or the "Company")

 

Completion of Acquisition

The Board of AMS (AIM: AMS), the global medical technology company, is pleased to announce that, following Admission of the 48,214,415 new Ordinary Shares in connection with the Placing and the Acquisition, the acquisition of RESORBA has now completed. 

 

For further information contact:

Advanced Medical Solutions

+44 (0) 1606 545 508

Chris Meredith, Chief Executive Officer

Mary Tavener, Group Finance Director

Investec Investment Banking (NOMAD)

+44 (0) 20 7597 5970

Gary Clarence

Patrick Robb

Daniel Adams

Cara Griffiths

 

Tavistock Communications

+44 (0) 20 7920 3150

John West

Chris Munden

Andrew Dunn

 

 

Investec Bank plc, which is authorised and regulated in the United Kingdom by the FSA, is acting as nominated adviser, broker and underwriter to AMS in relation to the Placing and Admission and is not acting for any other persons in relation to the Placing and Admission. Investec Bank plc is acting exclusively for AMS and for no one else in relation to the matters described in this announcement and is not advising any other person and accordingly will not be responsible to anyone other than AMS for providing the protections afforded to clients of Investec Bank plc, or for providing advice in relation to the contents of this announcement or any matter referred to in it. The responsibilities of Investec Bank plc as AMS's nominated adviser and broker under the AIM Rules for Companies and the AIM Rules for Nominated Advisers are owed solely to the London Stock Exchange and are not owed to AMS or to any Director, Shareholder or any other person, in respect of any decision to acquire or dispose of shares in the capital of AMS in reliance on any part of this announcement, or otherwise.

 

No liability is accepted by Investec Bank plc nor does it make any representation or warranty, express or implied, in relation to, the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by it, or on its behalf, in connection with the Company and the Placing and accordingly Investec Bank plc disclaims all and any responsibility or liability whether arising in tort, contract or otherwise which it might otherwise have in respect of this announcement or any such statement. Investec Bank plc has not authorised the contents, or any part, of this announcement. Investec Bank plc may, in accordance with applicable legal and regulatory provisions, engage in transactions in relation to the Ordinary Shares (including the Placing Shares) and/or related instruments for its own account for the purposes of hedging its underwriting exposure or otherwise. Except as required by applicable law or regulation, Investec Bank plc does not propose to make any public disclosure in relation to any such transactions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCVBLBLFLFFFBK
Date   Source Headline
1st May 20249:10 amRNSTotal Voting Rights
26th Apr 20249:17 amRNSDirector/PDMR Shareholding
25th Apr 20243:41 pmRNSHolding(s) in Company
17th Apr 20243:30 pmRNSHolding(s) in Company
4th Apr 20243:17 pmRNSHolding(s) in Company
2nd Apr 20242:47 pmRNSDirector/PDMR and PCA Shareholding
28th Mar 20245:04 pmRNSTotal Voting Rights
18th Mar 202412:35 pmRNSDirector/PDMR Shareholding
13th Mar 20247:03 amRNSProposed acquisition of Peters Surgical
13th Mar 20247:03 amRNSUnaudited Preliminary Results
12th Mar 20247:00 amRNSBlock listing Interim Review
10th Jan 20247:00 amRNSFull Year Trading Update
30th Nov 20235:11 pmRNSTotal Voting Rights
31st Oct 20235:02 pmRNSTotal Voting Rights
25th Oct 20237:00 amRNSUS LiquiBand® distribution agreements signed
2nd Oct 20237:01 amRNSDirector/PDMR Shareholding
2nd Oct 20237:00 amRNSAppointment of New Chair
27th Sep 20235:55 pmRNSDirector/PDMR Shareholding
25th Sep 20233:15 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSLiquiBand Fix8® US commercialisation agreement
14th Sep 20233:52 pmRNSBlock listing Interim Review
4th Sep 20237:00 amRNSTrading Statement
31st Aug 20235:56 pmRNSTotal Voting Rights
10th Aug 20237:00 amRNSNotice of Interim Results
31st Jul 20234:51 pmRNSTotal Voting Rights
11th Jul 20237:00 amRNSHalf Year Trading Update
30th Jun 20232:14 pmRNSTotal Voting Rights
19th Jun 202312:18 pmRNSStandard form for notification of major holdings
5th Jun 20237:00 amRNSUS regulatory approval granted for LiquiBandFix8®
31st May 20232:08 pmRNSResults of Annual General Meeting
31st May 20237:00 amRNSAnnual General Meeting
22nd May 20236:13 pmRNSDirector/PDMR Shareholding
28th Apr 20235:57 pmRNSTotal Voting Rights
26th Apr 20235:37 pmRNSAnnual Report and Notice of Annual General Meeting
18th Apr 20236:22 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:41 pmRNSTotal Voting Rights
27th Mar 20235:56 pmRNSDirector/PDMR and PCA Shareholding
22nd Mar 20235:52 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSUnaudited Preliminary Results
8th Mar 20232:56 pmRNSBlock listing announcement
28th Feb 20235:56 pmRNSTotal Voting Rights
14th Feb 20237:01 amRNSNotice of Results
1st Feb 20231:30 pmRNSAcquisition of Connexicon Medical
31st Jan 20233:17 pmRNSTotal Voting Rights
10th Jan 20237:00 amRNSFull Year Trading Update
3rd Jan 20237:00 amRNSTotal Voting Rights
30th Nov 20226:04 pmRNSTotal Voting Rights
28th Nov 20224:20 pmRNSChange of Registrar
31st Oct 20227:00 amRNSLiquiBandFix8® PMA application accepted by FDA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.